THE RELATIONSHIP OF ERECTILE DYSFUNCTION DRUGS USE WITH SEXUAL BEHAVIOUR AND SEXUALLY TRANSMITTED INFECTIONS AMONG MEN WHO HAVE SEX WITH MEN IN BELGRADE

  • Milan Bjekic City Institute for Skin and Venereal Diseases, Belgrade, Republic Serbia
  • Dubravka Salemovic Clinic of Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, Republic of Serbia
  • Hristina Vlajinac Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Republic Serbia
  • Jelena Marinkovic Institute of Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade, Republic of Serbia
DOI: https://doi.org/10.5937/zdravzast52-44488
Keywords: drugs, erectile dysfunction, men who have sex with men, sexual behaviour, sexually transmitted infections

Abstract


Background/Aim: Erectile dysfunction (ED) drugs are increasingly being used for recreational purposes and improving sexual performance. Oral phosphodiesterase 5 inhibitors are the most popular type of ED drugs among men who have sex with men (MSM). The aim of this study was to assess the prevalence of ED drugs use among MSM in Belgrade and its association with their behaviour and sexually transmitted infections.

Methods: A cross-sectional study was conducted at two public health care services in Belgrade and it covered 469 MSM. Data on demographic characteristics, sexual history, sexual behaviour, ED drugs and other recreational drugs use in the previous six months were collected from all participants by the use of a questionnaire.

Results: Of all 469 respondents, 16.2% have been using ED drugs. According to the results of multivariate logistic regression analysis, ED drugs users, compared to non-users were older (Odds Ratio – OR=2.60, Confidence interval – 95%CI 2.77-3.84, (p<0,001), had a greater number of sexual partners in the last six months (OR= 1.83, 95%CI 1.53-2.18, p<0.001), and more frequently used cannabis (OR=2.55, 95%CI 1.31-4.93, p=0.006) and chemsex in the past six months (OR=3.33, 95%CI 1.69-6.67, p<0.001).

Conclusion: ED drugs use among MSM is associated with higher levels of recreational drugs use and high-risk sexual behaviour. Educational messages about the risks and consequences of using ED drugs are needed. 

References

1. Bechara A, Casaba A, De Bonis W, Helien A, Bertolino MV. Recreative use of phosphodiesterase type 5 inhibitors by healthy young men. J Sex Med 2010; 7(11): 3736-3742. doi: 10.1111/j.1743-6109.2010.01965.x.

2. Park JW, Dobs AS, Ho KS, Palella FJ, Seaberg EC, Weiss RE, et al. Characteristics and longitudinal patterns of erectile dysfunction drug use among men who have sex with men in the U.S. Arch Sex Behav 2021; 50(7): 2887-2896. doi: 10.1007/s10508-021-02065-x.

3. Romero-Velez G, Lisker-Cervantes A, Villeda-Sandoval CI, Sotomayor de Zavaleta M, Olvera-Posada D, Sierra-Madero JG, et al. Erectile dysfunction among HIV patients undergoing highly active antiretroviral therapy: Dyslipidemia as a main risk factor. Sex Med 2014; 2(1):24-30.  doi:10.1002/sm2.25.

4. Hammoud MA, Jin F, Lea T, Maher L, Grierson J, Prestage G. Off-label use of phosphodiesterase type 5 inhibitor Erectile Dysfunction Medication to Enhance Sex among Gay and Bisexual Men in Australia: results from the FLUX Study. J Sex Med. 2017;14(6):774-84. doi: 10.1016/j.jsxm.2017.04.670.

5. Halkitis PN, Green KA. Sildenafil (Viagra) and club drug use in gay and bisexual men: The role of drug combinations and context. Am J Mens Health 2007, 1(2), 139-147. doi: 10.1177/1557988307300450.

6. Swearingen SG, Klausner JD. Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am J Med 2005, 118(6), 571-577.doi: 10.1016/j.amjmed.2005.01.042.

7. Fisher DG, Reynolds GL, Ware MR, Napper LE. Methamphetamine and Viagra use: Relationship to sexual risk behavior. Arch Sex Behav 2011;40(2):273-9. doi: 10.1007/s10508-009-9495-5.

8. Goltz HH, Coon DW, Catania JA, Latini DM. A pilot study of HIV/STI risk among men having sex with men using erectile dysfunction medications: Challenges and opportunities for sexual medicine physicians. J Sex Med 2012;9(12):3189-97. doi: 10.1111/j.1743-6109.2012.02943.x.

9. Ishikura F, Beppu S, Hamada T, Khandheria BK, Seward JB, Nehra A. Effects of sildenafil citrate (Viagra) combined with nitrate on the heart. Circulation. 2000; 102(20):2516-2521.doi 10.1161/01.cir.102.20.2516.

10. Babor T, Higgins-Biddle JC, Sounders JB, Monteiro MG. The alcohol use disorder identification test. Guidelines for use in primary care. Department of Mental Health and Substance Dependence, World Health Organization, 2001.

11. Prestage G, Jin FY, Bavinton B, Grulich A, Brown G, Pitts M, et al. Australian gay and bisexual men’s use of erectile dysfunction medications during recent sexual encounters. J Sex Med 2014;11(3):809-819. doi: 10.1111/jsm.12407.

12. Chu PL, McFarland W, Gibson S, Weide D, Henne J, Miller P, et al. Viagra use in a community-recruited sample of men who have sex with men, San Francisco. J AcquirImmune DeficSyndr 2003;33(2):191-3.doi: 10.1097/00126334-200306010-00012.

13. Kim A, Kent C, Klausner J. Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000–2001. AIDS 2002; 16(10):142-158. doi: 10.1097/00002030-200207050-00017.

14. Paul JP, Pollack L, Osmond D, Catania J. Viagra (Sildenafil) use in a population-based sample of U. S. men who have sex with men. Sex Transm Dis 2005; 32(9): 531-533.doi: 10.1097/01.olq.0000175294.76494.77.

15. Bjekić M, Šipetić-Grujičić S, Begović-Vuksanović B, Rafailović N, Vlajinac H. Syphilis resurgence in Belgrade, Serbia in the new millennium: an outbreak in 2014. Centr Eur J Public Health. 2017; 25(4): 277-81.doi: 10.21101/cejph.a4525.

16. Prestage GP, Grierson J, Bradley J, Hurley M, Hudson J. The role of drugs during group sex among gay men in Australia. Sex Health 2009;6(4):310-317. doi: 10.1071/SH09014.

17. Tomkins A, George R,  KlinerM. Sexualized drug taking among men who have sex with men: a systematic review. Perspect Public Health 2019; 139(1): 23-33. doi: 10.1177/1757913918778872.

18. McCarty-Caplan D, Jantz I, Swartz J. MSM and drug use a latent class analysis of drug use and related sexual risk behaviors. Aids Behav2014; 18(7): 1339-1351. doi: 10.1007/s10461-013-0622-x.

19. Fisher DG, Reynolds GL, Ware MR, Napper LE. Methamphetamine and Viagra use: Relationship to sexual risk behaviors. Arch Sex Behavior 2011; 40(2): 27-–279. doi: 10.1007/s10508-009-9495-5.

20. Crosby R, DiClemente RJ. Use of recreational Viagra among men having sex with men. Sex Transm Infect 2004; 80(6): 466-468. doi: 10.1136/sti.2004.010496.

21. European Monitoring Centre for Drugs and Drug Addiction. Serbia, National Drug Report 2017, Publications Office of the European Union, Luxembourg, 2017.

 

 

 

 

 

 

 

 

 

 

 

 

Published
2023/07/04
Issue
Vol. 52 No. 2 (2023): HEALTH CARE
Section
ORIGINAL ARTICLE